Company Filing History:
Years Active: 2001-2003
Title: The Innovations of Robert E. Bellet
Introduction
Robert E. Bellet is a notable inventor based in Elkins Park, Pennsylvania. He has made significant contributions to the field of cancer treatment, holding a total of 2 patents. His work focuses on innovative methods that aim to improve therapeutic outcomes for patients suffering from various forms of cancer.
Latest Patents
Among his latest patents, one is titled "Methods for Treatment of Renal Cell Carcinoma." This invention describes a method of treating renal cell carcinoma in mammals by administering a physiologically effective amount of an inhibitor of PDE10. Another significant patent is "Use of Docetaxel for Treating Cancers." This invention outlines a method of treating cancer that involves administering a dose of docetaxel alongside a dose of rhuMAb HER2, demonstrating a synergistic therapeutic effect compared to administering either treatment alone.
Career Highlights
Throughout his career, Robert E. Bellet has worked with prominent companies in the pharmaceutical industry, including Aventis Pharma S.A. and Cell Pathways. His experience in these organizations has contributed to his expertise in developing innovative cancer treatments.
Collaborations
Robert has collaborated with esteemed colleagues such as Charles L. Vogel and W. Joseph Thompson. Their combined efforts have further advanced the research and development of effective cancer therapies.
Conclusion
Robert E. Bellet's contributions to cancer treatment through his patents and collaborations highlight his dedication to improving patient outcomes. His innovative approaches continue to influence the field of oncology.